Global Neurology Academy

Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
NeuroFrontiers
Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
- Pavan Barghava, MD
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
NeuroFrontiers
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
- Michael Kornberg, MD, PhD
Managing Multiple Sclerosis: The Impact of Dietary Modifications
Managing Multiple Sclerosis: The Impact of Dietary Modifications
Global Neurology Academy
Managing Multiple Sclerosis: The Impact of Dietary Modifications
- Charles Turck, PharmD, BCPS, BCCCP
- Anna Shah, MD
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
NeuroFrontiers
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
- Cristin Welle, PhD
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
NeuroFrontiers
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
- Amy Kuceyeski, PhD
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
NeuroFrontiers
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
- Christopher Lock, MD
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
NeuroFrontiers
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
- David Kimhy, PhD
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
Global Neurology Academy
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
- Marisa McGinley, DO

Medical News

Medical News
Open-World Video Games Found to Boost Mental Well-Being in Postgraduate Students
medicalxpress.com
01/08/2025
Read more
Medical News
Innovative Haptic Belt Shows Promise for Improving Mobility in People With Vision Loss
sciencedaily.com
01/08/2025
Read more
Medical News
Socioeconomic Factors Tied to Brain Lesion Severity in Pediatric MS
medicalxpress.com
01/08/2025
Read more
Medical News
Smartphone App Reduces Opioid Use and Enhances Treatment Retention, Study Finds
news.uthscsa.edu
01/07/2025
Read more

See more news

CME/CE

Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
CME/CE
Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
0.25 credits
- Ahmed Zayed Obeidat, MD, PhD
0.25 credits
Brain Health in MS: A Comprehensive Approach
Brain Health in MS: A Comprehensive Approach
MinuteCE®
Brain Health in MS: A Comprehensive Approach
1.00 program credit
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
- Ahmed Zayed Obeidat, MD, PhD
1.00 program credit
Fluid Biomarkers: Revolutionizing MS Diagnosis
Fluid Biomarkers: Revolutionizing MS Diagnosis
MinuteCE®
Fluid Biomarkers: Revolutionizing MS Diagnosis
1.00 program credit
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
- Ahmed Zayed Obeidat, MD, PhD
1.00 program credit
Imaging Biomarkers: MS Progression in Focus
Imaging Biomarkers: MS Progression in Focus
MinuteCE®
Imaging Biomarkers: MS Progression in Focus
1.00 program credit
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
- Ahmed Zayed Obeidat, MD, PhD
1.00 program credit

Clinical Practice

From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
NeuroFrontiers
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
- Ashley Baker, MSN, PMHNP
- Steven Paul, MD
Exploring Metabolomics in Multiple Sclerosis
Exploring Metabolomics in Multiple Sclerosis
NeuroFrontiers
Exploring Metabolomics in Multiple Sclerosis
- Pavan Barghava, MD
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
NeuroFrontiers
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
- Dalia Rotstein, MD, MPH
Multiple Sclerosis Explained: Understanding Its Epidemiology
Multiple Sclerosis Explained: Understanding Its Epidemiology
NeuroFrontiers
Multiple Sclerosis Explained: Understanding Its Epidemiology
- Jonathan E. Howard, MD

Programs

Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
NeuroFrontiers
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
- Amber Salter, PhD
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
NeuroFrontiers
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
- Maxwell H. Levy, MD
Genetics and Schizophrenia: Key Ethical Considerations
Genetics and Schizophrenia: Key Ethical Considerations
NeuroFrontiers
Genetics and Schizophrenia: Key Ethical Considerations
- Aaron Besterman, MD
Recognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact
Recognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact
NeuroFrontiers
Recognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact